Clinical Trial Update: Safety and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase Ib/Phase II clinical trial update evaluating the safety and tolerability of Oshadi Icp in patients with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Oshadi Icp

Snippet

Sponsor: Oshadi Drug Administration | Conditions: Diabetes Mellitus, Insulin-Dependent, 1 | Phase 1, Phase 2 | Status: COMPLETED